These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8883405)
1. Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. Courage C; Snowden R; Gescher A Br J Cancer; 1996 Oct; 74(8):1199-205. PubMed ID: 8883405 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059 [TBL] [Abstract][Full Text] [Related]
3. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Courage C; Budworth J; Gescher A Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931 [TBL] [Abstract][Full Text] [Related]
4. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells. Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264 [TBL] [Abstract][Full Text] [Related]
5. Modulation of apoptosis in rat thymocytes by analogs of staurosporine: lack of direct association with inhibition of protein kinase C. Harkin ST; Cohen GM; Gescher A Mol Pharmacol; 1998 Oct; 54(4):663-70. PubMed ID: 9765509 [TBL] [Abstract][Full Text] [Related]
6. A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01. Eastman A; Kohn EA; Brown MK; Rathman J; Livingstone M; Blank DH; Gribble GW Mol Cancer Ther; 2002 Oct; 1(12):1067-78. PubMed ID: 12481430 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole. Akiyama T; Shimizu M; Okabe M; Tamaoki T; Akinaga S Anticancer Drugs; 1999 Jan; 10(1):67-78. PubMed ID: 10194549 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines. Lee SI; Brown MK; Eastman A Biochem Pharmacol; 1999 Dec; 58(11):1713-21. PubMed ID: 10571245 [TBL] [Abstract][Full Text] [Related]
9. Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines. Shimizu E; Zhao MR; Nakanishi H; Yamamoto A; Yoshida S; Takada M; Ogura T; Sone S Oncology; 1996; 53(6):494-504. PubMed ID: 8960146 [TBL] [Abstract][Full Text] [Related]
10. Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells. Ikegami Y; Yano S; Nakao K Arzneimittelforschung; 1996 Feb; 46(2):201-4. PubMed ID: 8720314 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cells. Ikegami Y; Yano S; Nakao K Jpn J Pharmacol; 1996 Jan; 70(1):65-72. PubMed ID: 8822090 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Wang Q; Worland PJ; Clark JL; Carlson BA; Sausville EA Cell Growth Differ; 1995 Aug; 6(8):927-36. PubMed ID: 8547221 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Seynaeve CM; Stetler-Stevenson M; Sebers S; Kaur G; Sausville EA; Worland PJ Cancer Res; 1993 May; 53(9):2081-6. PubMed ID: 7683251 [TBL] [Abstract][Full Text] [Related]
15. Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues. Jones T; Courage C; Hubbard A; Gescher A Biochem Pharmacol; 1997 May; 53(10):1413-8. PubMed ID: 9260867 [TBL] [Abstract][Full Text] [Related]
16. Analogs of staurosporine: potential anticancer drugs? Gescher A Gen Pharmacol; 1998 Nov; 31(5):721-8. PubMed ID: 9809468 [TBL] [Abstract][Full Text] [Related]
17. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells. Akinaga S; Nomura K; Gomi K; Okabe M Cancer Chemother Pharmacol; 1994; 33(4):273-80. PubMed ID: 7506638 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263 [TBL] [Abstract][Full Text] [Related]
19. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity. Begemann M; Kashimawo SA; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB Anticancer Res; 1998; 18(4A):2275-82. PubMed ID: 9703866 [TBL] [Abstract][Full Text] [Related]
20. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines. Dasmahapatra GP; Didolkar P; Alley MC; Ghosh S; Sausville EA; Roy KK Clin Cancer Res; 2004 Aug; 10(15):5242-52. PubMed ID: 15297428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]